Foster Delivery Science, a business unit of Foster Corporation, has broken ground on a new facility to support increased demand for manufacturing drug delivery and implant polymer blends. The facility is expected to be completed by May 1, 2015 at which time it will be registered with the Food and Drug Administration (FDA) to allow for processing active pharmaceutical ingredients (APIs).
For 11 years now, Foster Corporation has participated in the annual Quinnebaug Valley Community College (QVCC) Manufacturing Expo. This event brings together local manfacturing businesses and partners them with area high schools. Each partner team combines the capbilities of the host company, with the aspirations of the students to imagine, design and manufacture a product that improves the qualify of life.
Foster Corporation announced it ranked in Deloitte’s Technology Fast 500™, a ranking of the 500 fastest growing technology, media, telecommunications, life sciences and clean technology companies in North America. Foster Corporation grew 145% percent from 2008 to 2012.
Foster Polymer Distribution, a business unit of Foster Corporation has added Arkema Kynar® Rx 752 to its growing portfolio of medical grade polymers. This unique PVDF copolymer is USP Class VI compliant, chemical and autoclave resistant and can be processed using standard extrusion and injection molding equipment.
The annual Foster Golf Classic took place on Friday August 23rd at the Connecticut National Golf Club in Putnam, CT.
On August 10th 2013, members of the Foster Family participated in the 24th Annual Deary Memorial Road Race, sponsored by Day Kimball Heathcare. Each year, members of the Putnam, CT community walk, run and ride in support of the Deary Memorial Cancer Fund. Since inception in 1990, more than $1,000,000 has been raised to provide preventive care and cancer related services to individuals in our community.
Foster Corporation, a leader in custom polymers for medical devices, introduces ProPell™ thermoplastic polyurethane (TPU) and polyether block amide (PEBA) compounds for improved manufacturing and handling of medical catheters. These new compounds dramatically reduce tackiness and friction in soft, flexible polymers while maintaining other physical properties of the unmodified polymers.
Arkema Inc. recently introduced Rilsan® Clear G-170 MED, as a fully transparent polyamide for use in breathing masks, tubing and other transparent medical components. Rilsan® Clear G-170 MED is more transparent than glass and is 12% lighter than polycarbonate. In addition, Rilsan® Clear G-170 MED has a flexural modulus of 2,020 MPa (293,000 psi), representing a 16% improvement in flexibility compared to polycarbonate. These properties are necessary in those applications where patient comfort is required.
Foster Corporation now offers nano-reinforced composites for minimally invasive devices, such as catheters, with reinforcement loadings up to 30% by weight. Nano-reinforced compounds with high filler loadings provide substantial increase in physical properties of the base resin while maintaining processibility in thin wall components. Foster’s range of nano-reinforced compounds include nylons, TPEs and thermoplastic polyurethanes (TPUs).
Bill Blasius, Manager of Polymer Science at Foster Corporation recently participated in a Webinar Series with Hantel Technolgies to discuss the role of a custom compounder in medical device manufacturing. Webinar topics included an introduction to Foster Corporation, a background on Arkema Pebax® Polyamide Elastomers, a briefing of radiopacified polymers for catheter applications, a summary of nanocomposite compounds including properties & processes and finally a formulators perspective on device design possibilies.
- 1 of 2